InsiderClue
← All stocks

Relay Therapeutics, Inc.

RLAY Net selling
CIK 0001812364 #1471 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$129.02M
$5.86M on a plan · $4.79M straight out of an exercise
Sold at will
$118.37M
19 of 38 sales
Net
−$129.02M
−$118.37M against sales at will

By person

6 insiders · 38 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
SVF Pauling (Cayman) Ltd entity
10% owner
—
$116.40M (1)
−$116.40M
21,904,963
10.00%
$414.88M
−21.5%
Catinazzo Thomas
Chief Financial Officer
—
$5.18M (16) scheduled
−$5.18M
122,851
0.0561%
$2.33M
−54.6%
Patel Sanjiv
President and CEO
—
$3.61M (5) scheduled
−$3.61M
1,605,951
0.7328%
$30.42M
−31.0%
Bergstrom Donald A
President, R&D
—
$2.36M (8) scheduled
−$2.36M
399,130
0.1821%
$7.56M
−10.1%
Rahmer Peter
See remarks
—
$1.47M (8) scheduled
−$1.47M
223,657
0.1021%
$4.24M
−34.8%
Adams Brian
Chief Legal Officer
—
—
—
371,472
0.1695%
$7.04M
+14.7%

Individual transactions

38
Insider
Date
Role
Action
Shares
Price
Amount
Patel Sanjiv
8 Sep 2026
President and CEO
Sold on a plan
48,199
$18.94
$912.89K
Catinazzo Thomas
8 Sep 2026
Chief Financial Officer
Sold on a plan
17,717
$18.94
$335.56K
Bergstrom Donald A
8 Sep 2026
President, R&D
Sold on a plan
8,530
$18.97
$161.81K
Rahmer Peter
26 Aug 2026
See remarks
Sold on a plan
4,508
$20.03
$90.30K
SVF Pauling (Cayman) Ltd
25 Aug 2026
10% owner
Sell indirect
6,000,000
$19.40
$116.40M
Patel Sanjiv
17 Aug 2026
President and CEO
Sold on a plan
48,199
$20.33
$979.89K
Catinazzo Thomas
14 Aug 2026
Chief Financial Officer
Sold on a plan
17,717
$19.74
$349.73K
Bergstrom Donald A
28 Jul 2026
President, R&D
Sell
2,237
$18.61
$41.63K
Rahmer Peter
28 Jul 2026
See remarks
Sell
748
$18.61
$13.92K
Catinazzo Thomas
28 Jul 2026
Chief Financial Officer
Sell
1,459
$18.61
$27.15K
Patel Sanjiv
7 Jul 2026
President and CEO
Sold on a plan
48,199
$19.58
$943.74K
Catinazzo Thomas
6 Jul 2026
Chief Financial Officer
Sold on a plan
17,717
$18.69
$331.13K
Bergstrom Donald A
6 Jul 2026
President, R&D
Sold on a plan
8,660
$18.71
$162.03K
Rahmer Peter
30 Jun 2026
See remarks
Sold on a plan
50,000
$19.09
$954.50K
Bergstrom Donald A
22 Jun 2026
President, R&D
Sold after exercise
93,456
$16.94
$1.58M
Catinazzo Thomas
22 Jun 2026
Chief Financial Officer
Sold after exercise
51,560
$16.97
$874.97K
Catinazzo Thomas
22 Jun 2026
Chief Financial Officer
Sold after exercise
61,563
$16.97
$1.04M
Catinazzo Thomas
22 Jun 2026
Chief Financial Officer
Sold after exercise
56,323
$16.97
$955.80K
Catinazzo Thomas
22 Jun 2026
Chief Financial Officer
Sold after exercise
17,717
$17.01
$301.37K
Catinazzo Thomas
14 May 2026
Chief Financial Officer
Sold on a plan
17,717
$12.86
$227.84K
Bergstrom Donald A
28 Apr 2026
President, R&D
Sell
1,490
$14.79
$22.04K
Rahmer Peter
28 Apr 2026
See remarks
Sell
753
$14.79
$11.14K
Catinazzo Thomas
28 Apr 2026
Chief Financial Officer
Sell
972
$14.79
$14.38K
Catinazzo Thomas
9 Apr 2026
Chief Financial Officer
Sold after exercise
1,800
$15.00
$27.00K
Catinazzo Thomas
7 Apr 2026
Chief Financial Officer
Sold on a plan
17,717
$13.01
$230.50K
Catinazzo Thomas
9 Mar 2026
Chief Financial Officer
Sold on a plan
17,717
$10.06
$178.23K
Catinazzo Thomas
28 Jan 2026
Chief Financial Officer
Sell
1,695
$8.45
$14.32K
Rahmer Peter
28 Jan 2026
See remarks
Sell
1,354
$8.45
$11.44K
Bergstrom Donald A
28 Jan 2026
President, R&D
Sell
2,686
$8.45
$22.70K
Catinazzo Thomas
27 Jan 2026
Chief Financial Officer
Sell
13,820
$7.62
$105.31K
Rahmer Peter
27 Jan 2026
See remarks
Sell
11,684
$7.62
$89.03K
Bergstrom Donald A
27 Jan 2026
President, R&D
Sell
18,895
$7.62
$143.98K
Patel Sanjiv
6 Jan 2026
President and CEO
Sell
43,168
$7.82
$337.57K
Patel Sanjiv
3 Nov 2025
President and CEO
Sell
62,073
$7.00
$434.51K
Rahmer Peter
29 Oct 2025
See remarks
Sell
21,394
$7.50
$160.46K
Bergstrom Donald A
28 Oct 2025
President, R&D
Sell
30,897
$7.29
$225.24K
Catinazzo Thomas
28 Oct 2025
Chief Financial Officer
Sell
21,664
$7.29
$157.93K
Rahmer Peter
28 Oct 2025
See remarks
Sell
19,135
$7.29
$139.49K

What was left out

Form 4 filings counted 43
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 13
Sales straight out of an exercise 6
Sales at will 19
Transactions with no price 0
Shares from compensation/vesting 272,802
History held since 20 Jul 2020